AI assistant
Emami Ltd Investor Presentation 2021
61637_rns_2021-08-02_e51ee171-251d-4949-b374-0d992f5482ff.pdf
Investor Presentation
Open in viewerOpens in your device viewer
ernaml limited
Date: 2°c1 August, 2021
The Secretary The National Stock Exchange of India Ltd. Exchange Plaza, Plot No. C/1, G. Block Bandra Kurla Complex, Bandra (E) Mumbai - 400 051
The Secretary BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001
Dear Sirs,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copy of Investor Presentation on Company's Performance for the first quarter ended 3QLh June, 2021.
The aforesaid information is also given 011 the website of the company www.emamiltd.in
This is for your information and record.
Thanking You, Yours Sincerely,
For Emami Limited
?
A. K. Joshi Company Secretary & VP- Legal (Encl. : As above)
Q1FY22 Revenue Growth
| Growth | in Q1FY22 over | Q1FY22 Revenue Split | |||
|---|---|---|---|---|---|
| Key Financials | Q1FY21 | Q1FY20 | Institutional | ||
| • Domestic Business |
42% | 5% | 3% | ||
| • International Business |
17% | -9% | International 12% |
||
| • Institutional Business |
34% | -17% | |||
| Consolidated Net Sales | 38% | 2% | Domestic 85% |
||
| • Other Operating Income |
-21% | -34% | |||
| Total Revenues | 37% | 2% |
- ▹ 2% growth in Net Sales over Q1FY20 despite impact of 2nd wave of COVID
- ▹ 38% volume growth in Domestic Business
Brandwise Performance (Domestic)
| Q1FY22 growth over |
|||||
|---|---|---|---|---|---|
| Key Brands | Q1FY21 | Q1FY20 | |||
| Healthcare Range | 59% | 95% | |||
| Pain Management Range |
70% | 95% | |||
| Navratna Range |
21% | -29% | |||
| Kesh King Range | 53% | 2% | |||
| BoroPlus Range (excl. Sanitizer) |
96% | 32% | |||
| Male Grooming Range | 78% | -47% | |||
| 7 Oils in One | 93% | 17% |
New Launches / Packaging Updates
Navratna Therapy Range Launched on e-commerce platforms - Flipkart, Amazon & Nykaa
HE Active Range
With core claim – "bacteria gone, odour gone" Launched in MT; e-commerce launch in July
Zandu Pancharishta
Introduced dosage cap for convenience and driving volume growth
Ad Campaigns
Influencer Marketing
Navratna Student Digital Campaigns with popular YouTube influencers – "Dear Sir", "Mahatmaji Technical" and "English Connection"
YouTube and Instagram Campaigns for Zandu Ayurvedic Chywanprash with Jaggery with popular influencers
Navratna MAXX Cool Talc Digital Campaign with popular influencers Aadil Khan, Shirish, Anjali Arora and Niti Taylor
Katrina Kaif promoted 7 Oils in One from her Instagram handle
Digital connect for Zandu Balm with expert videos –Yoga Instructor, leading physiotherapist
7
Digital Activities
Zandu Immunity eBook published in partnership with 1mg. 5 million consumers reached via mail & push notification, with engagement of ~1.2 million
Zandu Immunity Quiz used to educate and drive awareness among consumers about Zandu Products on Amazon.
3.2 lac consumers completed the quiz highlighting benefits across 5 products of Zandu
Zandu Participated in Health, Hygiene wellness week on Amazon. 95 million impressions generated
E Campaigns for various Zandu Products
International Business Performance
- ▹ Sales grew by 17% over PY
- ▹ SAARC & SEA, CIS and Africa grew strongly
- ▹ Creme 21 extended to Premium skin soaps in 4 variants.
- SEA South East Asia (Major countries – Malaysia, Myanmar & Singapore)
- MENA Middle East & North Africa (Major countries – UAE, Qatar, Oman, Kuwait, Bahrain etc.)
- CIS Commonwealth of Independent States (Major Countries – Russia, Ukraine etc.)
Q1FY22 Profitability (Consolidated)
| Q1FY22 | ₹ in crore |
Growth over Q1FY21 |
Growth over Q1FY20 |
Margins | Margin Growth over Q1FY21 |
Margin Growth over Q1FY20 |
|---|---|---|---|---|---|---|
| Revenues | 661 | 37% | 2% | |||
| Gross Profit | 436 | 36% | 5% | 66.0% | -50 bps | +180 bps |
| EBIDTA | 170 | 38% | 27% | 25.7% | +20 bps | +500 bps |
| PAT | 78 | 97% | 98% | 11.8% | +350 bps | +570 bps |
| Cash Profit |
161 | 41% | 31% | 24.3% | +50 bps | +540 bps |
▹ Record profits and margins despite pandemic and input cost pressure
Q1FY22 Financial Analysis
Cost of Goods Sold (as a % of sales) +50 bps
Staff Costs (as a % of sales) -340 bps
A&P Costs (as a % of sales)
+420 bps
Admin & Other Exp (as a % of sales) -140 bps
Q1FY22 Summarized Financials
₹ in Millions
| Particulars | Q1FY22 | % | Q1FY21 | % | Growth | FY21 | % |
|---|---|---|---|---|---|---|---|
| Net Sales | 6,542.4 | 99.0% | 4,728.2 | 98.2% | 38.4% | 28,542.6 | 99.1% |
| Other Operating Income | 67.1 | 1.0% | 85.2 | 1.8% | -21.2% | 262.7 | 0.9% |
| Revenue from Operations | 6,609.5 | 100.0% | 4,813.4 | 100.0% | 37.3% | 28,805.3 | 100.0% |
| Materials Cost | 2,246.2 | 34.0% | 1,613.4 | 33.5% | 39.2% | 9,292.3 | 32.3% |
| A&P | 1,098.6 | 16.6% | 597.1 | 12.4% | 84.0% | 4,581.3 | 15.9% |
| Staff Cost | 845.0 | 12.8% | 781.3 | 16.2% | 8.2% | 3,091.7 | 10.7% |
| Admn & Other Exp | 722.6 | 10.9% | 591.8 | 12.3% | 22.1% | 3,009.4 | 10.4% |
| EBIDTA | 1,697.1 | 25.7% | 1,229.8 | 25.5% | 38.0% | 8,830.6 | 30.7% |
| Other Income | 107.2 | 1.6% | 67.0 | 1.4% | 60.0% | 702.7 | 2.4% |
| Interest | 6.4 | 0.1% | 47.0 | 1.0% | -86.4% | 132.7 | 0.5% |
| Amortisation of acquired TM's/ brands | 596.1 | 9.0% | 554.3 | 11.5% | 7.5% | 2,678.5 | 9.3% |
| Depreciation/Amortisation of other assets | 233.9 | 3.5% | 193.6 | 4.0% | 20.8% | 991.0 | 3.4% |
| PBT | 967.9 | 14.6% | 501.9 | 10.4% | 92.9% | 5,731.1 | 19.9% |
| Tax | 174.8 | 2.6% | 94.8 | 2.0% | 84.4% | 1,142.1 | 4.0% |
| PAT | 793.1 | 12.0% | 407.1 | 8.5% | 94.8% | 4,589.0 | 15.9% |
| Share of Minority Interest & P/L of Associate | (15.2) | -0.2% | (11.1) | -0.2% | 36.9% | (41.9) | -0.1% |
| PAT After Minority Interest & Associate | 777.9 | 11.8% | 396.0 | 8.2% | 96.5% | 4,547.1 | 15.8% |
| Cash Profit (PAT + Dep. & Amortization) | 1,607.9 | 24.3% | 1,143.9 | 23.8% | 40.6% | 8,216.6 | 28.5% |
| EPS Rs - |
1.75 | 0.88 | 10.23 | ||||
| Cash EPS Rs - |
3.62 | 2.54 | 18.48 |
